AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2020
Mar 3, 2020
29755_dirs_2020-03-03_24230af6-74a5-44d6-8358-0a435159ed6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-02-28
Reporting Person: SALEKI-GERHARDT AZITA (EVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-28 | Common Stock, $0.01 par value | F | 16342 | $85.42 | Disposed | 113867 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 2027 | Indirect |
| Common Stock, $0.01 par value | 3873 | Indirect |
Footnotes
F1: Balance in AbbVie Savings program as of February 24, 2020.
F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4